Haemonetics Corporation (HAE) Q4 2020 Earnings Results

Haemonetics Corp Misses on EPS, Stock Down 3.34%

The earnings report indicates that Haemonetics Corp faced some challenges, resulting in a slight miss on EPS. The stock reacted negatively, dropping 3.34% in response to the results and management's cautious tone. Investors may be concerned about the company's ability to navigate current market conditions without specific guidance for the future.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.69	N/A	-4.83%

Management

Management commentary

Tone: Cautiously Optimistic

Management acknowledged the difficulties faced during the quarter but expressed confidence in the company's strategic direction. They highlighted ongoing efforts to adapt to market changes.

Management noted challenges due to the current market environment.

They emphasized a focus on long-term growth despite short-term hurdles.

Haemonetics Corp Misses on EPS, Stock Down 3.34%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corp Misses on EPS, Stock Down 3.34%

Key numbers

Management commentary